5-Amino-1MQ

Small-molecule NNMT inhibitor studied in metabolic and adipose-research models.

5-Amino-1MQ is supplied by Bench Grade Peptides as a lyophilized powder in a sealed, lot-numbered vial, for laboratory research use only — not for human or veterinary use.

Its published Certificate of Analysis (lot 00011, analyzed July 21, 2026) is from Bioviridian, a third-party laboratory, and reports 99.8% purity by HPLC; every published lot is listed on the product's COA page. Vials ship at ambient temperature in protective packaging from Florida (Bench Grade Peptides LLC is registered in Dover, Delaware), with storage notes on the lot's certificate.

5-Amino-1MQ is not a peptide. It is a small-molecule quinolinium compound, 5-amino-1-methylquinolinium, which the catalogue carries because it is studied alongside peptides in the same metabolic-research programmes.

Its research interest comes from its target: nicotinamide N-methyltransferase (NNMT), the enzyme that methylates nicotinamide and in doing so draws on the cell's S-adenosylmethionine and NAD+ precursor pools. Published work, including Neelakantan et al. in Biochemical Pharmacology (2018), describes 5-Amino-1MQ as a selective, cell-permeable NNMT inhibitor and examines it in cultured adipocytes and in diet-induced rodent models.

As a small molecule it is analysed differently from a peptide: identity rests on its mass and structure rather than on a sequence. Published lot certificates are listed on its COA page. 5-Amino-1MQ is supplied for laboratory research use only.

Research use only. Everything on this page describes laboratory research. This compound is supplied strictly for in-vitro research use; it has not been evaluated or approved by the FDA and is not for human or veterinary use, and nothing here is a protocol or a recommendation.

Researchers also ordered